Find out more about six immunology companies that have recently raised impressive funds in the biotech industry.

President Xi Jinping don promise say im go step up di support wey China dey give kontris for Africa wey dey owe dem wit funding of nearly $50 billion ova three years. China leader wey make dis ...

Electricity companies Central Maine Power and Versant Power said they comply with the state's rules. Limited ratepayer funds can be used for some programming crucial to utilities' operations, but all ...

Sept. 4, 2024 /PRNewswire/ -- Subtle Medical, a leader in AI-powered medical imaging solutions, is proud to announce that it has been awarded Phase II funding of its NIH SBIR grant to further develop ...

On Thursday, Versant Power said it had updated one of its substations in advance of the University of Maine’s fall semester. According to the company, it had updated equipment at UMaine’s Steam Plant ...

In the U.S., project financing offers businesses a way to secure funding for large-scale projects like infrastructure, telecommunications, and energy. Project finance is a method to fund large ...

Aug 28 (Reuters) - OpenAI, the startup behind the popular ChatGPT, is reportedly in discussions to raise billions of dollars in a new funding round that could see it valued at above $100 billion ...

Alzheimer’s disease research and drug development is evolving at a rapid pace. Decades of research has led to the approval of the first disease-modifying drugs and new pathological discoveries.

Borealis Biosciences, which launched Thursday with $150 million from Versant Ventures and an options deal with Novartis, is the latest example. It’s the second build-to-buy funding deal Versant has ...

Novartis has partnered with Versant Ventures to establish Borealis ... Novartis will offer upfront plus near-term research funding of up to $100, and holds the option for the acquisition of ...

Vancouver-based Borealis Biosciences has emerged from stealth with $150 million USD ($202 million CAD) in backing from San Francisco-based founding investor Versant Ventures and ... in upfront and ...

Novartis has partnered with Versant Ventures to establish Borealis Biosciences ... Novartis will offer upfront plus near-term research funding of up to $100, and holds the option for the acquisition ...